Skip to main content
Veterinary Medicines

Nobivac DHP

Authorised
  • Canine distemper virus, strain Onderstepoort, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Canine parvovirus, strain 154, Live

Product identification

Medicine name:
Нобивак ДХП
Nobivac DHP
Active substance:
  • Canine distemper virus, strain Onderstepoort, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Canine parvovirus, strain 154, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain Onderstepoort, Live
    4.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine adenovirus 2, strain Manhattan LPV3, Live
    4.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine parvovirus, strain 154, Live
    7.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD02
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-1977
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 23/08/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 23/08/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 23/08/2024